Powder extensively hydrolysed formula (0913101) vs Pdr disc/non ACBS protein SfI metabolic condition (0913445)
Powder extensively hydrolysed formula (0913101) was dispensed 502.5× as often as Pdr disc/non ACBS protein SfI metabolic condition (0913445) in June 2026 — 39,198 items versus 78 in England.
Powder extensively hydrolysed formula (0913101) · June 2026
NHSBSA Prescription Cost Analysis
Pdr disc/non ACBS protein SfI metabolic condition (0913445) · June 2026
NHSBSA Prescription Cost Analysis
Figure 1. Powder extensively hydrolysed formula (0913101) versus Pdr disc/non ACBS protein SfI metabolic condition (0913445): national items dispensed by month
▬ Powder extensively hydrolysed formula (0913101) · ╌ Pdr disc/non ACBS protein SfI metabolic condition (0913445)
Source: NHSBSA Prescription Cost Analysis, to June 2026
| Measure | Powder extensively hydrolysed formula (0913101) | Pdr disc/non ACBS protein SfI metabolic condition (0913445) |
|---|---|---|
| Items, June 2026 | 39,198 | 78 |
| Items, last 12 months | 486,024 | 872 |
| Net ingredient cost, June 2026 | £2,984,500 | £48,292 |
See the full profile for Powder extensively hydrolysed formula (0913101) or Pdr disc/non ACBS protein SfI metabolic condition (0913445).